Skip to content
★ Sign in to follow
DB
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 23 Dec 2025 for OptimizeRx Corp, €44k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Doug Besch: trading record in brief

Doug Besch is a declared insider of OptimizeRx Corp, with filings sourced from SEC (Form 4). In total, 15 filings cover trades dated from 3 October 2023 to 23 December 2025.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 23 December 2025: a share grant of €44k, in OptimizeRx Corp. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Doug Besch

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ◆
    Chief Product & Tech OfficerExecutivesOptimizeRx Corp
    51,966 USD17SEC
    4,079 shares@ US$12.7464.3% of flowCommon StockSEC:0001628280-25-058761:0
  • ◇
    Chief Product & Tech OfficerExecutivesOptimizeRx Corp
    0SEC
    1,964 shares0Common StockSEC:0001628280-25-058408:0
  • ◆
    Chief Product & Tech OfficerExecutivesOptimizeRx Corp
    18,431 USD13SEC
    983 shares@ US$18.7522.9% of flowCommon StockSEC:0001628280-25-044540:1
  • ◇
    Chief Product & Tech OfficerExecutivesOptimizeRx Corp
    0SEC
    3,325 shares0Common StockSEC:0001628280-25-044540:0
  • ◆
    Chief Prod & Tech OfficerExecutivesOptimizeRx Corp
    0SEC
    15,625 shares0Common StockSEC:0001628280-25-041108:0
  • ◆
    Chief Product OfficerExecutivesOptimizeRx Corp
    9,203 USD12SEC
    1,386 shares@ US$6.6412.8% of flowCommon StockSEC:0001628280-25-006690:0
  • ◆
    Chief Product OfficerExecutivesOptimizeRx Corp
    0SEC
    41,408 shares0Common StockSEC:0001628280-24-052485:0
  • ◇
    Chief Product OfficerExecutivesOptimizeRx Corp
    0SEC
    1,964 shares0Common StockSEC:0001628280-24-052285:0
  • ◇
    Chief Product OfficerExecutivesOptimizeRx Corp
    0SEC
    3,324 shares0Common StockSEC:0001628280-24-042474:0
  • ◆
    Chief Product OfficerExecutivesOptimizeRx Corp
    0SEC
    4,000 shares0Common StockSEC:0001628280-24-017551:0
  • ◇
    Chief Product OfficerExecutivesOptimizeRx Corp
    0SEC
    3,324 shares0Common StockSEC:0001628280-23-034058:0

11 of 11 declarations